News
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment for menopause.
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
Hormone therapies for menopause have come with black box warnings for decades. Our wellness expert explains why this could soon change.
The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...
Hormone Therapy Controversy Raises Drug Safety Issues. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2005 / 02 / 050223125120.htm ...
Susan Dentzer reports on the controversy over hormone replacement therapy for women. Full Episode. ... Women’s Health Debate Oct 3, 2002 12:00 AM EDT. ... and stroke from one key hormone drug.
A recent study that questioned the benefits of hormone replacement therapy caused a lot of concern for many women who were planning to take treatments for the rest of their lives. Now the ...
The debate over hormone-replacement therapy is heating up again. A group of researchers announced plans for a broad new study to determine whether hormone-replacement therapy can help prevent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results